Skip to main content
Premium Trial:

Request an Annual Quote

I Spy With My Little Software Package

The US Food and Drug Administration has allegedly been conducting surveillance on some of its scientists to rein in criticism of the agency's medical device review process, reports The New York Times. The Times says the effort began as an investigation of five scientists who were thought to be leaking confidential information about medical device safety and grew into a program that tracked emails those agency scientists sent to lawmakers, journalists, and others. FDA used a commercially available spy software package to capture the scientists' keystrokes and screen images as well as to copy documents. While federal agencies may monitor employees' computer use, the Times notes that FDA may have gathered confidential communications, like those between lawyers and clients as well as whistleblower complaints. The Times adds that FDA has developed a list of people thought to working to put out negative information about the agency. The agency says its action was limited to the five scientists thought to be leaking information. FDA adds that while it did track communications, it was only to see whether those scientists were sharing information improperly.

The Scan

Renewed Gain-of-Function Worries

The New York Times writes that the pandemic is renewing concerns about gain-of-function research.

Who's Getting the Patents?

A trio of researchers has analyzed gender trends in biomedical patents issued between 1976 and 2010 in the US, New Scientist reports.

Other Uses

CBS Sunday Morning looks at how mRNA vaccine technology could be applied beyond SARS-CoV-2.

PLOS Papers Present Analysis of Cervicovaginal Microbiome, Glycosylation in Model Archaea, More

In PLOS this week: functional potential of the cervicovaginal microbiome, glycosylation patterns in model archaea, and more.